![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Tactio Scores Both ANVISA and CE Mark for TactioRPM App-Enabled Telehealth Platform
Tactio Scores Both ANVISA and CE Mark for TactioRPM App-Enabled Telehealth Platform
February 8, 2017
The Brazilian Health Regulatory Agency (ANVISA) and French National Agency for Medicines and Health Products Safety (ANSM) recognized Tactio Health Group’s CE Mark for its TactioRPM app-enabled telehealth platform.
TactioRPM is an app-enabled platform that combines mobile apps with health integrations (i.e. the Fitbit wireless-enabled wearable device), patient questionnaires, digital coaching programs and HIPAA-compliant messaging.
TactioRPM received FDA clearance in 2015. — Cynthia Jessup
Upcoming Events
-
21Oct